Abbott (ABT) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
BofA/Merrill Lynch Upgrades Abbott Labs (ABT) to Buy
January 30, 2015 6:58 AM ESTBofA/Merrill Lynch upgraded Abbott Labs (NYSE: ABT) from Neutral to Buy with a price target of $52.00 (from $50.00).
Analyst Bob Hopkins cited three things, including: 1) ABT's strong Q4 results yesterday, which suggest estimates have bottomed with strong revenue growth and margin expansion highly likely... More
